$NFTN
NFiniTi inc.

2021 Q4 Form 10-K Financial Statement

#000147793221008795 Filed on November 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.74K
YoY Change 1556.84%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $15.74K
YoY Change 1556.74%
Operating Profit -$15.74K
YoY Change 1556.74%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$15.74K
YoY Change 1556.74%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$15.74K
YoY Change 1556.74%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 20.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.553K $6.550K $7.353K
YoY Change -10.88% -10.88%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $73.34K
YoY Change 29.12%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $79.89K $79.89K $64.15K
YoY Change 24.53% 24.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $79.89K $79.89K $64.15K
Total Long-Term Liabilities $0.00
Total Liabilities $79.89K
YoY Change 24.54%
SHAREHOLDERS EQUITY
Retained Earnings -$139.9K -$124.2K
YoY Change 12.68%
Common Stock $120.0K $20.00K
YoY Change 500.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$79.89K -$79.89K -$64.15K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$15.74K
YoY Change 1556.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$16.54K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $16.54K
YoY Change
NET CHANGE
Cash From Operating Activities -$16.54K
Cash From Investing Activities
Cash From Financing Activities $16.54K
Net Change In Cash $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$16.54K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20000000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20000000 shares
CY2021Q4 us-gaap Cash
Cash
0 USD
CY2020Q4 us-gaap Cash
Cash
0 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2021Q4 us-gaap Assets
Assets
0 USD
CY2020Q4 us-gaap Assets
Assets
0 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6553 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7353 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3305 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
73340 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
56801 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
79893 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
64154 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
40000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-139893 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124154 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-79893 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-64154 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021 us-gaap Revenues
Revenues
0 USD
CY2020 us-gaap Revenues
Revenues
0 USD
CY2021 us-gaap Professional Fees
ProfessionalFees
15739 USD
CY2020 us-gaap Professional Fees
ProfessionalFees
950 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
15739 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
950 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-15739 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-950 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-15739 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-950 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-63204 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-950 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-64154 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-15739 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-79893 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-15739 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-950 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-800 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
950 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16539 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
16539 USD
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16539 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2021 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
200 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20000000 shares
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
CY2021Q4 aoix Working Capital Deficit
WorkingCapitalDeficit
79893 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-139893 USD
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
16539 USD
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-15739 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-950 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-15739 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-950 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3305 USD
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
200 USD
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3305 USD
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
200 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3305 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
200 USD
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
139893 USD
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
124154 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
29377 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26072 USD
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
29377 USD
CY2020Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
26072 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD

Files In Submission

Name View Source Status
0001477932-21-008795-index-headers.html Edgar Link pending
0001477932-21-008795-index.html Edgar Link pending
0001477932-21-008795.txt Edgar Link pending
0001477932-21-008795-xbrl.zip Edgar Link pending
aoix-20211031.xsd Edgar Link pending
aoix-20211031_cal.xml Edgar Link unprocessable
aoix-20211031_def.xml Edgar Link unprocessable
aoix-20211031_lab.xml Edgar Link unprocessable
aoix-20211031_pre.xml Edgar Link unprocessable
aoix_10k.htm Edgar Link pending
aoix_10k_htm.xml Edgar Link completed
aoix_ex31.htm Edgar Link pending
aoix_ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending